Osteal Therapeutics
Dallas, TX · Healthcare, Health Care, Other · 49 employees
Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.
Funding history
- Funding Round — $15.6M — Nov 2025
- Funding Round — $50.0M — Jun 2024
- Funding Round — $23.0M — Sep 2023
- Funding Round — $22.3M — Sep 2023
- Series series b — $30.0M — Mar 2022
Recent signals
- Nov 05, 2025: Raised $15.6M
- Jun 06, 2024: Raised $50.0M
- Sep 21, 2023: Raised $23.0M
- Sep 12, 2023: Raised $22.3M
- Mar 08, 2022: Raised $30.0M in Series series b
- Jan 26, 2022: Raised $2.0M in Series pre-seed
- Jan 12, 2021: Raised $2.0M
- Nov 23, 2020: Raised $1.5M in Series seed
See plans & pricing → Track Osteal Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.